Betsos et al. démontrent que les revendeurs de drogues ont utilisé des informations provenant de la vérification des drogues pour minimiser les risques liés au fentanyl et maintenir la confiance de leurs clients. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.


By Alex Betsos, Jenna Valleriani, Jade Boyd, Geoff Bardwell, Thomas Kerr & Ryan McNeil

Drug sellers are often represented as morally bereft actors and as being, in part, responsible for North America's overdose crisis. In Canada and the United States, drug sellers selling fentanyl and fentanyl-adulterated drugs have been charged with manslaughter when their clients fatally overdose, representing a retrenchment of drug war tactics. However, targeting drug sellers for drug checking interventions may have potential for reducing fentanyl-related harms. This study explores drug sellers’ negotiation of and engagement with drug checking technologies in Vancouver, Canada.

Rapid ethnographic fieldwork was conducted from November 2018 to January 2019, including 26 semi-structured interviews with people who tested their drugs at an overdose prevention site to examine perceptions of the efficacy of drug checking. As drug sellers were also using the drug checking services, we specifically examined their perceptions of drug checking and the market aspects of the overdose crisis. Data were analyzed using Nvivo 12 and interpreted drawing on the concept of structural vulnerability.